Utility of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for an In Vitro Model of Proliferative Vitreoretinopathy (Q90952571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

18 April 2020

review article

1 reference

title

Utility of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for an In Vitro Model of Proliferative Vitreoretinopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

proliferative vitreoretinopathy

18 April 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

18 April 2020

author name string

Whitney A Greene

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

18 April 2020

Ramesh R Kaini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

18 April 2020

publication date

1 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

Advances in Experimental Medicine and Biology

18 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

18 April 2020

volume

1186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

18 April 2020

page(s)

33-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

Embryo-derived stem cells: of mice and men.

18 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Nuclear reprogramming in cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Establishment in culture of pluripotential cells from mouse embryos

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Organogenesis in a dish: modeling development and disease using organoid technologies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Concise review: drug discovery in the age of the induced pluripotent stem cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Disease-specific induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

New lessons learned from disease modeling with induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Generation of germline-competent induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

The bioethics of stem cell research and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Recombinant xeno-free vitronectin supports self-renewal and pluripotency in protein induced pluripotent stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Alternative sources of pluripotent stem cells: ethical and scientific issues revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Concise review: Genomic instability in human stem cells: current status and future challenges.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Genomic instability in pluripotent stem cells: implications for clinical applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Induced pluripotent stem cell lines derived from human somatic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Generation of induced pluripotent stem cells using site-specific integration with phage integrase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Human induced pluripotent stem cells free of vector and transgene sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

A comparison of non-integrating reprogramming methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Deriving retinal pigment epithelium (RPE) from induced pluripotent stem (iPS) cells by different sizes of embryoid bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Retinoid uptake, processing, and secretion in human iPS-RPE support the visual cycle.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Patient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Patient-Specific Induced Pluripotent Stem Cell-Derived RPE Cells: Understanding the Pathogenesis of Retinopathy in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Unilateral subretinal fibrosis and uveitis syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Massive submacular fibrosis after ocular blunt injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Occlusion of retinal capillaries caused by glial cell proliferation in chronic ocular inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Controversies in orbital reconstruction-III. Biomaterials for orbital reconstruction: a review with clinical recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Controversies in orbital reconstruction--II. Timing of post-traumatic orbital reconstruction: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Controversies in orbital reconstruction--I. Defect-driven orbital reconstruction: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Traumatic maculopathy 6 months after injury: a clinical case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Punctate inner choroidopathy: a clinical case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Closed-Eye Ocular Injuries in the Iraq and Afghanistan Wars

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Combat ocular trauma and systemic injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy: risk factors and pathobiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Outcomes of transconjunctival sutureless 25-gauge vitrectomy with silicone oil infusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Primary retinal detachment repair: comparison of 1-year outcomes of four surgical techniques

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Scleral buckling procedures for longstanding or chronic rhegmatogenous retinal detachment with subretinal proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Retinotomy and silicone oil for detachments complicated by anterior inferior proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Primary retinectomy in proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Heavy silicone oil versus standard silicone oil in as vitreous tamponade in inferior PVR (HSO Study): interim analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Oxane HD vs silicone oil and scleral buckle in retinal detachment with proliferative vitreoretinopathy and inferior retinal breaks

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Safety and feasibility of a novel intravitreal tamponade using a silicone oil/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Rhegmatogenous Retinal Detachment with a High Risk of Proliferative Vitreoretinopathy Treated with Episcleral Surgery and an Intravitreal Dexamethasone 0.7-mg Implant

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Ozurdex (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Role of daunorubicin in inhibiting proliferative vitreoretinopathy after retinal detachment surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Effect of Serial Intrasilicone Oil Bevacizumab Injections in Eyes With Recurrent Proliferative Vitreoretinopathy Retinal Detachment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Clinical management of proliferative vitreoretinopathy: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Pathophysiology of proliferative vitreoretinopathy in retinal detachment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Risk factors for proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Glial cell proliferation in retinal detachment (massive periretinal proliferation)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Inflammatory cells in proliferative vitreoretinopathy subretinal membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Epitheliomesenchymal transdifferentiation of cultured RPE cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Transforming growth factor-beta1 induces alpha-smooth muscle actin expression and fibronectin synthesis in cultured human retinal pigment epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Matrix and the retinal pigment epithelium in proliferative retinal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

In vivo models of proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

The retinal pigment epithelium: an important player of retinal disorders and regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Transforming growth factor beta in experimentally detached retina and periretinal membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Factors influencing myofibroblast differentiation during wound healing and fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Myofibroblasts and mechano-regulation of connective tissue remodelling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

The myofibroblast in wound healing and fibrocontractive diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Growth Factors in Vitreous and Subretinal Fluid Cells from Patients with Proliferative Vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

A Novel Strategy to Develop Therapeutic Approaches to Prevent Proliferative Vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

PDGF receptors are activated in human epiretinal membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Role of retinal pigment epithelial cell β-catenin signaling in experimental proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

The complex interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

The PI3K/Akt pathway mediates the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Snail Involves in the Transforming Growth Factor β1-Mediated Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

MicroRNA-29b regulates TGF-β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells by targeting AKT2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Thrombin induces slug-mediated E-cadherin transcriptional repression and the parallel up-regulation of N-cadherin by a transcription-independent mechanism in RPE cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Factor Xa and thrombin stimulate proinflammatory and profibrotic mediator production by retinal pigment epithelial cells: a role in vitreoretinal disorders?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Functional characteristics of connective tissue growth factor on vitreoretinal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Enhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Ceramide inhibits connective tissue growth factor expression by human retinal pigment epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Growth factors outside the PDGF family drive experimental PVR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Modulation of basic fibroblast growth factor effect by retinoic acid in cultured retinal pigment epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-28471-8_2

10.1007/978-3-030-28471-8_2

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31654385 AND SRC:MED&resulttype=core&format=json

18 April 2020

1 reference